Table 5.
Response
| Best Response | n=21 |
|---|---|
| Partial Response | 1 (4.8%) |
| Stable Disease | 9 (42.9%) |
| Progressive Disease | 7 (33.3%) |
| Unevaluable * | 4 (19.0%) |
*
Patients came off treatment prior to completing cycle 1 due to a Dose-Limiting Toxicity
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.